Carol Fabian, M.D., co-leader for the KU Cancer Center’s Cancer Prevention Program, has been named the 2013 Komen Kansas City Legacy Promise Award recipient.
Dr. Fabian directs the Breast Cancer Prevention and Survivorship Centers at the KU Cancer Center where she and her team have conducted numerous early phase prevention trials focusing on reducing breast cancer while improving overall health and quality of life.
In 2010, Dr. Fabian received a $4.5 million Promise Grant from Susan G. Komen for the Cure to investigate whether an estrogen found in flax seed - a commonly used supplement - can reduce the risk of breast cancer. In addition to her work in Kansas City, Dr. Fabian serves as a Komen Scholar, providing expertise to Susan G. Komen for the Cure in a variety of capacities including responsibility for leading and participating as a reviewer in Komen's scientific peer review process.
Roy Jensen, M.D., director of the KU Cancer Center, has been named Honorary Medical Alumnus as part of the 2013 University of Kansas Medical Cancer Alumni Awards.
The Honorary Alumni Awards are presented to non-graduates of the University of Kansas Medical Center (KUMC) who have made significant impact through their professional or personal contributions.
The award recognizes an individual’s noteworthy contributions in his or her field, professional or personal contributions to KU or KUMC, and contributions to health care with special consideration given to those having a national or global impact.
Kirsten Erickson, Ph.D. has joined the KU Cancer Center as senior director of the Clinical Research Office. She will be responsible for all financial, regulatory, and clinical trial operational aspects of the Oncology Clinical Research Office.
Dr. Erickson will play a key role in strategic planning, program management and business development for the office. She was most recently assistant director of the Clinical Trials Office at the Rebecca and John Moores University of California San Diego Cancer Center where she developed clinical trials start-up processes and oversaw regulatory submissions. She received her Ph.D. in Public Health, Epidemiology/Biostatisics, from the University of California - San Diego.
Brooke Fridley, Ph.D., is director of the Bio Informatics Shared Resource for the KU Cancer Center. In her role, she oversees staff and helps cancer center members develop grants and protocols.
Dr. Fridley was previously associate professor of Biostatistics at the Mayo Clinic and has extensive experience in the study design and analysis of genomic studies. She received her Ph.D. in statistics from Iowa State University.